News

Amgen and Kite Pharma are to collaborate on the development of novel Chimeric Antigen Receptor (CAR) T cell immunotherapies based on Kite's engineered autologous cell therapy (eACT) platform and Amgen's cancer targets. Seen as the 'next...

US-based Gilead Sciences has entered into an agreement with German Phenex Pharmaceuticals to acquire its Farnesoid X Receptor (FXR) programme, including small molecule FXR agonists to treat liver diseases comprising nonalcoholic steatohepatitis (NASH). As part of...

Pfizer has purchased a controlling stake in Redvax, a spin-off from Swiss biopharmaceutical firm Redbiotec. Terms of the transaction were not disclosed.Redvax is a preclinical stage company, which develops multi-component virus-like particles (VLPs) and other protein...

Scientists from US-based Johns Hopkins Kimmel Cancer Centre have developed a statistical model, which measures the proportion of cancer incidence across many tissue types caused by random mutations. Random mutations occur when stem cells divide.Johns Hopkins...

Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. Mylan received non-exclusive rights to manufacture and distribute TAF as both a single agent...

The trial will examine oral beta secretase cleaving enzyme (BACE) inhibitor AZD3293, also known as LY3314814, which reduced levels of amyloid-beta in the cerebro-spinal fluid of Alzheimer's patients and healthy volunteers in phase I studies. Other...

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine. Led by Washington University breast cancer surgeon and senior author...